Angelini Pharma acquires ThermaCare® from GSK

Slider Thermacare Newtest
  • Published: 20 Jun 2020

Angelini Pharma has acquired the ThermaCare® global business rights from GSK.

The European Commission has formally approved a deal for GSK to sell its rights for ThermaCare® Heat Wraps globally (excluding North America) to Angelini Pharma.

The deal also includes the dedicated US manufacturing site for ThermaCare in Albany (Georgia).